Evidence map›Paper›PMID 24373350›Full record

ArticleThe Journal of allergy and clinical immunology2014

Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.

Laurence Menard, Tineke Cantaert, Nicolas Chamberlain, Stuart G Tangye, Sean Riminton, Joseph A Church, Amy Klion, Charlotte Cunningham-Rundles, Kim E Nichols, Eric Meffre

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Homeostasis and regulation of autoreactive B cells.Cellular & molecular immunology · 2020
    Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The ups and downs of negative (and positive) selection of B cells.The Journal of clinical investigation · 2015
    Article
  19. B lymphocytes in neuromyelitis optica.Neurology(R) neuroimmunology & neuroinflammation · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Laurence MenardDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Tineke CantaertDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Nicolas ChamberlainDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Stuart G TangyeImmunology Program, Garvan Institute of Medical Research, and St Vincent's Clinical School, University of New South Wales, Darlinghurst, Australia.
Sean RimintonDepartment of Immunology, Concord Hospital, Sydney, Australia.
Joseph A ChurchDivisions of Clinical Immunology and Allergy, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, Calif.
Amy KlionLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Charlotte Cunningham-RundlesDepartment of Medicine, Immunology Institute, Mt Sinai School of Medicine, New York, NY.
Kim E NicholsDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Eric MeffreDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn. Electronic address: eric.meffre@yale.edu.
Yale University · USChildren's Hospital of Philadelphia · USConcord Repatriation General Hospital · AUNational Institutes of Health · USUniversity of Southern California · USUNSW Sydney · AU

Funding

Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
Eosinophils and Eosinophil Activation in the Pathogenesis of Human DiseaseZIAAI001130 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KLION, AMY · 2010 to 2025
$22.5M
Loss of B Cell Tolerance in Rheumatoid ArthritisR01AI071087 · NIAID · YALE UNIVERSITY · PI MEFFRE, ERIC · 2006 to 2016
$4.3M
Yale Autoimmunity Center of ExcellenceU19AI082713 · NIAID · YALE UNIVERSITY · PI HEROLD, KEVAN C · 2009 to 2013
$3.6M
Human and Translational ImmunologyT32AI089704 · NIAID · YALE UNIVERSITY · PI HEROLD, KEVAN C · 2010 to 2014
$994k
Impact of regulatory T cells on human peripheral B cell toleranceR21AI095848 · NIAID · YALE UNIVERSITY · PI MEFFRE, ERIC · 2012 to 2013
$457k
Intramural NIH HHSNIAID NIH HHS AI061093NIAID NIH HHS AI071087NIAID NIH HHS AI082713NIAID NIH HHS AI095848NIAID NIH HHS P01 AI061093NIAID NIH HHS R01 AI071087NIAID NIH HHS R21 AI095848NIAID NIH HHS T32 AI089704NIAID NIH HHS U19 AI082713
6 · The paper itself

Abstract

backgroundSignaling lymphocytic activation molecule (SLAM)-associated protein (SAP) can mediate the function of SLAM molecules, which have been proposed to be involved in the development of autoimmunity in mice.

objectiveWe sought to determine whether the SLAM/SAP pathway regulates the establishment of human B-cell tolerance and what mechanisms of B-cell tolerance could be affected by SAP deficiency.

methodsWe tested the reactivity of antibodies isolated from single B cells from SAP-deficient patients with X-linked lymphoproliferative disease (XLP). The expressions of SAP and SLAM family members were assessed in human bone marrow-developing B cells. We also analyzed regulatory T (Treg) cell function in patients with XLP and healthy control subjects.

resultsWe found that new emigrant/transitional B cells from patients with XLP were enriched in autoreactive clones, revealing a defective central B-cell tolerance checkpoint in the absence of functional SAP. In agreement with a B cell-intrinsic regulation of central tolerance, we identified SAP expression in a discrete subset of bone marrow immature B cells. SAP colocalized with SLAMF6 only in association with clustered B-cell receptors likely recognizing self-antigens, suggesting that SLAM/SAP regulate B-cell receptor-mediated central tolerance. In addition, patients with XLP displayed defective peripheral B-cell tolerance, which is normally controlled by Treg cells. Treg cells in patients with XLP seem functional, but SAP-deficient T cells were resistant to Treg cell-mediated suppression. Indeed, SAP-deficient T cells were hyperresponsive to T-cell receptor stimulation, which resulted in increased secretion of IL-2, IFN-γ, and TNF-α.

conclusionsSAP expression is required for the counterselection of developing autoreactive B cells and prevents their T cell-dependent accumulation in the periphery.

Indexed as

Immune ToleranceSignal TransductionAntigens, CDAutoimmunityB-Cell Activating FactorB-LymphocytesGene ExpressionHumansIntracellular Signaling Peptides and ProteinsLymphocyte ActivationLymphoproliferative DisordersProtein BindingProtein TransportReceptors, Antigen, B-CellReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Associated ProteinAntigens, CDB-Cell Activating FactorIntracellular Signaling Peptides and ProteinsReceptors, Antigen, B-CellReceptors, Cell SurfaceSH2D1A protein, humanSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule FamilySignaling Lymphocytic Activation Molecule Family Member 1SLAMF6 protein, humanSlamf6 protein, mouseTNFSF13B protein, humanB-cell toleranceregulatory T cellssignaling lymphocytic activation moleculeSLAM-associated protein

Identifiers

PMID24373350
PMCPMC4077428
OpenAlexW2004040654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.